21CFRPart11ElectronicRecords&ElectronicSignatu.ppt

Click to edit Master title style,Click to edit Master text styles,Second level,Third level,Fourth level,Fifth level,Slide No.,*,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,21 CFR Part 11Electronic Records&Electronic Signatures,Svend Martin Fransen,Principal Scientist,QS CRS Quality Services,Novo Nordisk A/S,Slide No.,2,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Contents,21CFR11 history,The important aspects of 21CFR11,Equivalent requirements in EU legislation,The Novo Nordisk 21 CFR11 compliance project,Examples,Experiences learned,Slide No.,3,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Contents,21CFR11 history,The important aspects of 21CFR11,Equivalent requirements in EU legislation,The Novo Nordisk 21 CFR11 compliance project,Examples,Experiences learned,Slide No.,4,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,It has gradually become common knowledge that,knowledge is the most important resource in the business of the future.,It is the ability to,create,new knowledge and the ability to,utilize and organize,existing knowledge that will be the primary source for,obtaining lasting competitive advantages.,Peter Holdt Christensen:”Viden om”ledelse,viden og virksomheden,Why do we have computers?,Slide No.,5,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,What is 21CFR11?,21CFR=FDA,C,ode of,F,ederal,R,egulations,21CFR58=,GLP,21CFR210=GMP,Drugs(General),21CFR211=GMP,Drugs(Finished Pharmaceuticals),21CFR312=Inv.New drug Application(GCP),21CFR314=FDA Approval of new drug(GCP),21CFR6xx=GMP,biologics,21CFR820=GMP,Devices,21CFR=Food,nutrients and cosmetics,21CFR11=Electronic Records;Electronic Signatures,Slide No.,6,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,What is 21CFR11?,21CFR=FDA,C,ode of,F,ederal,R,egulations,21CFR58=,GLP,21CFR210=GMP,Drugs(General),21CFR211=GMP,Drugs(Finished Pharmaceuticals),21CFR312=Inv.New drug Application(GCP),21CFR314=FDA Approval of new drug(GCP),21CFR6xx=GMP,biologics,21CFR820=GMP,Devices,21CFR=Food,nutrients and cosmetics,21CFR11=Electronic Records;Electronic Signatures,Slide No.,7,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Historic overview,A wish from the Industry(use of ES),FDA:,Final Draft i 1994,Final Rule 20.March.1997,effective from 20.Aug.1997,4,draft,guidelines,Glossary of Terms,Validation,Time stamps and Maintenance of ER,GAMP Part 11 guide,published Nov.2001(part 2),PDA”GERM”guide,published Sep.2002(part 1),PDA”GERM”guide Models,expected 2003(part 3),Slide No.,8,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Contents,21CFR11 history,The important aspects of 21CFR11,Equivalent requirements in EU legislation,The Novo Nordisk 21 CFR11 compliance project,Examples,Experiences learned,Slide No.,9,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,21CFR11,Overview,Substantive rule from 20 August 1997,Applies to any e-record in any FDA regulated work including legacy systems,Criteria for e-records and e-signatures:,Trustworthy and reliable,E-signatures=hand-written signatures,Minimum requirements/fraud prevention,Slide No.,10,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Systems not Applications,All definitions and clauses in 21 CFR 11 refer to systems,Application is not mentioned,IT part of the GXP environment.,Do they know?,Working environment,Computer based system,Computer system,Application,-software,Platform,-hardware,-system SW,Controlled function,Instructions,Manuals,etc.,Equipment,COMPUTER RELATED SYSTEM,Slide No.,11,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,21 CFR Part 11,Basics,Electronic records equivalent with paper records,Storage,retrieval and copying in full retention period,Submitting to FDA,Protection of electronic records,Security(physical and logical),Validation,Audit trail(who did what,when including reason where req.),Permission to use of electronic signature,Equivalent with handwritten signatures,Name,date and meaning,Linking of signature to record,Unique for an individual,Slide No.,12,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,21 CFR Part 11,Basics,Electronic records equivalent with paper records,Storage,retrieval and copying in full retention period,Submitting to FDA,Protection of electronic records,Security(physical and logical),Validation,Audit trail(who did what,when including reason where req.),Permission to use of electronic signature,Equivalent with handwritten signatures,Name,date and meaning,Linking of signature to record,Unique for an individual,Slide No.,13,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,ORA,Compliance Policy Guide CPG 7153.17(May 1999),Acknowledging not all older systems fully compliant by Aug 20,1997,firms must take steps to achieve full compliance,Regulatory actions based on case by case evaluation,FDA auditors should intensify their scrutiny of e-recs,Calls for firms to,have a reasonable timetable,promptly modify any system not in compliance,be able to demonstrate progress,have procedural controls in place by now,Slide No.,14,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,FDA 21CFR11 inspection questions,(source:,:21CFR11 Compliance Report,Vol.2,No.4).,Who is allowed to input data?,Who is allowed to change data?,How can you tell who entered the data?,How do you know which data had been changed?,When do you lock down the data input?,Can you do the following actions?“Show me some data,show me you can see the history of the data,show me you control the data life cycle.”,Is the system validated and are the requirements met?,Can you show me the results of the validation activities?,Does the validation include:“Pass/fail,signature,date/time stamp”;and“objective evidence-screen prints or page printouts with a link to the direction that generated the output.”?,Slide No.,15,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Earlham College,Warning Letter,In addition to the above listed violations,our Investigator noted that the laboratory is using an electronic record system for processing and storage of data from the atomic absorption and HPLC instruments that is,not set up to control the security and data integrity in that the system is not password controlled,there is no systematic back-up provision,and,there is no audit trail of the system capabilities.,The system does not appear to be designed and controlled in compliance with the requirements of 21 CFR,Part 11,Electronic Records.,Slide No.,16,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Contents,21CFR11 history,The important aspects of 21CFR11,Equivalent requirements in EU legislation,The Novo Nordisk 21 CFR11 compliance project,Examples,Experiences learned,Slide No.,17,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,EU,Annex 11,Computerised Systems,Personnel,Validation,System,Descriptions and SOPs,Change control and configuration management,Records;entry,storage,retrieval,Audit trail,Security and Disaster recovery,etc.,Slide No.,18,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,EU,Annex 11,Computerised Systems,Personnel,Validation,System,Descriptions and SOPs,Change control and configuration management,Records;entry,storage,retrieval,Audit trail,Security and Disaster recovery,etc.,Slide No.,19,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,PIC/S Draft Guidance,Good Practices for Computerised Systems in regulated”GXP”environment,Computer System Life cycle,incl.,Electronic Records and Signatures,Security,and,Audit trail,Checklists for Inspection,Links ISO and IEEE standards,21CFR11,APV guides,PDA Technical Reports together,Slide No.,20,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Quote from PIC/S Guide,21.ELECTRONIC RECORDS AND ELECTRONIC SIGNATURES,21.1,EC Directive 91/356 sets out the legal requirements for EU GMP,.The GMP obligations include a requirement to maintain a system of documentation,(Article 9).The main requirements in Article 9.1 are that documents are clear,legible and up to date,that the system of documentation makes it possible to trace the history of manufacture(and testing)of each batch and that the records are retained for the required time.,Article 9.2 envisages that this documentation may be electronic,photographic or in the form of another data processing system,rather than written,.The main requirements here being that the regulated user has validated the system by proving that the system is able to store the data for the required time,that the data is made readily available in legible form and that the data is protected against loss or damage.,Slide No.,21,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Draft Proposal for a Commission Directive(30.Apr.2002),Amending Commission Directive 91/356/EEC,Laying Down the Principles and Guidelines of Good Manufacturing Practice for Medicinal Products for Human Use,When electronic,photographic or other data processing systems are used instead of written documents,the manufacturer or importer shall have,validated the systems,by proving that the data will be,appropriately stored,during the anticipated period of storage.Data stored by these systems shall be made,readily available in legible form,and shall,be provided on demand,to the competent authorities.For an investigational medicinal product when electronic,photographic or other data processing systems are used instead of written documents the manufacturer or importer shall have validated the systems to maintain the data during the required period of storage.Data stored by these systems shall be readily available in legible form and shall be provided on demand to the competent authorities.,Slide No.,22,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Contents,21CFR11 history,The important aspects of 21CFR11,Equivalent requirements in EU legislation,The Novo Nordisk 21 CFR11 compliance project,Examples,Experiences learned,Slide No.,23,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,21CFR11 Compliance Project,Purpose,Assist the units/system owners to prioritise the activities necessary to get in compliance over a limited period of time.,Scope,All Computer Systems within Novo Nordisk that,generate electronic records covered by regulatory requirements from FDA,including the systems that utilise Electronic Signatures,Slide No.,24,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,21CFR11 Compliance Project,Purpose,Assist the units/system owners to prioritise the activities necessary to get in compliance over a limited period of time.,Scope,All Computer Systems within Novo Nordisk that,generate electronic records covered by regulatory requirements from FDA,including the systems that utilise Electronic Signatures,Slide No.,25,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Overview of the 21CFR11 compliance project,Product,Supply,Staffs,Quality,RA,and other,Development,21CFR11 project,No.of systems today=868(PS)+219(Dev.)+65(others)=1152 systems,(.and more to come),Slide No.,26,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,21CFR11 Compliance Project,Tasks,Secure cGxP for 21CFR11 at Novo Nordisk,Maintain corporate policy and interpretations,Responsible for project QAP reporting,Participate in external groups as NN representatives,Distribute knowledge to organisation through,Training(short courses and Site specific),Knowledge and guidance database,Project web page,Guidelines,Slide No.,27,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Guidance database,-,web-enabled,Slide No.,28,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Identify and register systems(overview),Prioritise systems,Evaluate”high-risk”system,s,Evaluate”medium-and low-risk”systems,Evaluate corrections/solutions,Prepare implementation plan,”Quick fixes”,”Full compliance,technical and procedural,Implement solutions,Activities in relation to Part 11,Slide No.,29,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Prioritisation of systems,Regulatory Risk,Factor,based on:No.of records generated by the system,no.of users,frequency of use and system complexity,High risk,Low risk,Medium risk,Medium risk,Y,X,Non-GxP systems(17),Other GxP critical,systems(11),GxP,support systems(20),Slide No.,30,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Prioritisation of systems,Regulatory Risk,Factor,based on:No.of records generated by the system,no.of users,frequency of use and system complexity,High risk,Low risk,Medium risk,Medium risk,Y,X,Non-GxP systems(17),Other GxP critical,systems(11),GxP,support systems(20),Slide No.,31,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Gradual achievement of compliance,20,20,20,20,50,40,60,Phase 1:Implement Site and system procedures,Phase 2:Technology based solutions,etc.,Phase,1,Phase,2,Slide No.,32,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Deliverables from common workgroups,Evaluation of the system(gap-analysis)for technical issues,Evaluation of possible solutions,Recommendations and other input from supplier(s),Recommended solutions,including,Draft or example of procedures,Description of technical solution,Estimated costs,Suggested implementation plan,Slide No.,33,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Progress Follow Up,=On track,=Ensure no further delay,=Take action to catch up,Site,System registration QA,approved,System evaluation on,track,Implementation plan,preparation on track,A,LL,K,L,B,LL,J,J,C,J,J,J,D,J,J,K,E,J,K,LLL,F,J,K,K,G,J,LL,L,H,J,J,J,I,J,J,J,J,J,K,K,K,LL,J,K,L,LL,J,J,Example,Slide No.,34,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Kaye Validator,SCADA(Fix32),Filter testing equipment(PALL),Instron(replacement for.),PE laboratory equipment(UV/VIS+.)incl.replacements for.),Usifroid freeze dryer,BMS(building monitoring systems),.more to come(due to standardisation),Examples of Pilot projects in production area,Slide No.,35,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Contents,21CFR11 history,The important aspects of 21CFR11,Equivalent requirements in EU legislation,The Novo Nordisk 21 CFR11 compliance project,Examples,Experiences learned,Slide No.,36,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Contents,21CFR11 history,The important aspects of 21CFR11,Equivalent requirements in EU legislation,The Novo Nordisk 21 CFR11 compliance project,Examples,Experiences learned,Slide No.,37,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,What can go wrong,will.,HPCE,(High Pressure Capillary Electrophoresis),Scenario:Replacement of chromatography software to Millennium and setting up an archive installation,7 year old software,HW requirements to PC,Migration of ER from OS/2 to Win NT,Indexation of migrated data,ER on tape stored in safe,Use of archive installation,Training of users,SOPs,Slide No.,38,QS CRS Quality Services/Svend Martin Fransen ,03.Oct.2002,Further information:www.zignx.dk/,A hardware solution:,Control power supply to individual physical entities i